We are live on
!
Find out more
DHFB
Dixon Hubard Feinour & Brown Portfolio holdings
AUM
$842M
1-Year Est. Return
2.74%
This Fund
S&P 500
This Quarter
Est. Return
+3.89%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
–
AUM
$322M
AUM Growth
+$9.28M
(+3%)
Cap. Flow
+$1.33M
Cap. Flow
% of AUM
0.41%
Top 10 Holdings %
Top 10 Hldgs %
24.44%
Holding
184
New
17
Increased
42
Reduced
59
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$6.21M |
| 2 |
Accenture
ACN
|
+$5.86M |
| 3 |
Labcorp
LH
|
+$5.52M |
| 4 |
Electronic Arts
EA
|
+$5.12M |
| 5 |
Lam Research
LRCX
|
+$4.42M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$7.03M |
| 2 |
Kroger
KR
|
+$5M |
| 3 |
Mohawk Industries
MHK
|
+$4.88M |
| 4 |
SLB Ltd
SLB
|
+$3.51M |
| 5 |
Marathon Petroleum
MPC
|
+$3.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.09% |
| 2 | Technology | 14.53% |
| 3 | Industrials | 11.48% |
| 4 | Communication Services | 9.95% |
| 5 | Consumer Discretionary | 6.61% |
Similar funds
BDWM
MCM
TFM
MWM
CP
BWM
FPS
IC
Dixon Hubard Feinour & Brown's Q3 2016 Portfolio in Review
As of Q3 2016, Dixon Hubard Feinour & Brown held 184 positions worth $322M, up 3% from $313M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Dixon Hubard Feinour & Brown's Q3 2016 filing shows 17 new, 42 increased, 59 reduced and 13 closed positions. Its largest new stake was Amgen: 36,700 shares worth $6.12M. The largest sale was CVS Health, an estimated $7.03M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.
- Dixon Hubard Feinour & Brown's largest Q3 2016 buy was Amgen: 36,700 shares worth $6.12M.
- Dixon Hubard Feinour & Brown added most to Travelers Companies in Q3 2016, an estimated $821K increase.
- Dixon Hubard Feinour & Brown's biggest Q3 2016 reduction was SLB Ltd, cutting an estimated $3.51M.
- Dixon Hubard Feinour & Brown fully exited CVS Health in Q3 2016, selling an estimated $7.03M.
- Dixon Hubard Feinour & Brown's ten largest holdings make up 24% of its $322M portfolio in Q3 2016.
- Dixon Hubard Feinour & Brown opened 17 new positions and closed 13 in Q3 2016.
- Dixon Hubard Feinour & Brown's portfolio value rose 3% quarter-over-quarter to $322M.
Based on Dixon Hubard Feinour & Brown's 13F filing for Q3 2016, filed 9 Nov 2016.